In addition, expression of maspin reduces metastasis of breast cancer cells via repressing urokinase plasminogen activator (uPA)/urokinase plasminogen activator receptor (uPAR) complex, which enhances the cleavage of a number of extracellular matrix proteins through activating plasminogen [35]. Here, SERPINB5 is linked to breast cancer.